Mutation in the β2m gene is not a frequent event in head and neck squamous cell carcinomas
- 1 August 1999
- journal article
- Published by Elsevier in Human Immunology
- Vol. 60 (8) , 697-706
- https://doi.org/10.1016/s0198-8859(99)00015-4
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Implications for immunosurveillance of altered HLA class I phenotypes in human tumoursImmunology Today, 1997
- Roles for Calreticulin and a Novel Glycoprotein, Tapasin, in the Interaction of MHC Class I Molecules with TAPImmunity, 1996
- Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinial relevanceImmunology Today, 1995
- Folding and assembly of major histocompatibility complex class I heterodimers in the endoplasmic reticulum of intact cells precedes the binding of peptide.The Journal of Experimental Medicine, 1993
- Natural history of HLA expression during tumour developmentImmunology Today, 1993
- Peptides Naturally Presented by MHC Class I MoleculesAnnual Review of Immunology, 1993
- HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptidesNature, 1992
- HLA antigen expression in routinely processed head and neck squamous cell carcinoma primary lesions of different sitesInternational Journal of Cancer, 1991
- HLA-A- and HLA-B-specific monoclonal antibodies reactive with free heavy chains in Western blots, in formalin-fixed, paraffin-embedded tissue sections and in cryo-immuno-electron microscopyInternational Immunology, 1990
- Antigen Recognition by Class I-Restricted T LymphocytesAnnual Review of Immunology, 1989